Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription Factor

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Courapied, Sandy ^a   Cherier, Julia ^a   Vigneron, Arnaud ^a   Troadec, Marie Bérangère ^c   Giraud, Sandrine ^d   Valo, Isabelle ^b   Prigent, Claude ^c   Gamelin, Erick ^a   Coqueret, Olivier ^a   Barré, Benjamin ^a  

^a CENTRE PAUL PAPIN   (France)

^b Biopathology Department   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; DNA TOPOISOMERASE; MAX PROTEIN; MYC PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MAD; TRANSCRIPTION FACTOR MIZ1; UNCLASSIFIED DRUG; AURORA KINASE; PRIMER DNA; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE OVEREXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; PROGNOSIS; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECT; GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; DNA TOPOISOMERASES, TYPE I; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 77955104660     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-205     Document Type: Article

References (36)

1. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003, 3:421-429. 10.1016/S1535-6108(03)00110-7, 12781359.
2. Su TT. Cellular responses to DNA damage: one signal, multiple choices. Annu Rev Genet 2006, 40:187-208. 10.1146/annurev.genet.40.110405.090428, 16805666.
3. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004, 432:338-341. 10.1038/nature03099, 15549096.
4. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002, 2:594-604. 10.1038/nrc864, 12154352.
5. Mailand N, Falck J, Lukas C, Syljuasen RG, Welcker M, Bartek J, Lukas J. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000, 288:1425-1429. 10.1126/science.288.5470.1425, 10827953.
6. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997, 277:1501-1505. 10.1126/science.277.5331.1501, 9278512.
7. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H, Elledge SJ. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997, 277:1497-1501. 10.1126/science.277.5331.1497, 9278511.
8. Fang G, Yu H, Kirschner MW. The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev 1998, 12:1871-1883. 10.1101/gad.12.12.1871, 316912, 9637688.
9. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998, 20:189-193. 10.1038/2496, 9771714.
10. Giet R, Petretti C, Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link?. Trends Cell Biol 2005, 15:241-250. 10.1016/j.tcb.2005.03.004, 15866028.
11. Meraldi P, Honda R, Nigg EA. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr Opin Genet Dev 2004, 14:29-36. 10.1016/j.gde.2003.11.006, 15108802.
12. Meraldi P, Honda R, Nigg EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. Embo J 2002, 21:483-492. 10.1093/emboj/21.4.483, 125866, 11847097.
13. Krystyniak A, Garcia-Echeverria C, Prigent C, Ferrari S. Inhibition of Aurora A in response to DNA damage. Oncogene 2006, 25:338-348.
14. Pommier Y, Redon C, Rao VA, Seiler JA, Sordet O, Takemura H, Antony S, Meng L, Liao Z, Kohlhagen G, et al. Repair of and checkpoint response to topoisomerase I-mediated DNA damage. Mutat Res 2003, 532:173-203.
15. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat Rev Cancer 2006, 6:789-802. 10.1038/nrc1977, 16990856.
16. Bienvenu F, Barre B, Giraud S, Avril S, Coqueret O. Transcriptional Regulation by a DNA-associated Form of Cyclin D1. Mol Biol Cell 2005, 16:1850-1858. Epub 2005 Jan 1819, 10.1091/mbc.E04-08-0654, 1073666, 15659654.
17. Barré B, Vigneron A, Coqueret O. The STAT3 transcription factor is a target for the Myc and retinoblastoma proteins on the Cdc25A promoter. J Biol Chem 2005, 280:15673-15681. 10.1074/jbc.M413203200, 15677471.
18. Barre B, Perkins ND. The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol Cell 2010, 38:524-538. 10.1016/j.molcel.2010.03.018, 20513428.
19. Vigneron A, Gamelin E, Coqueret O. The EGFR-STAT3 oncogenic pathway up-regulates the Eme1 endonuclease to reduce DNA damage after topoisomerase I inhibition. Cancer Res 2008, 68:815-825. 10.1158/0008-5472.CAN-07-5115, 18245483.
20. Vigneron A, Cherier J, Barre B, Gamelin E, Coqueret O. The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J Biol Chem 2006, 281:34742-34750. 10.1074/jbc.M602492200, 16923815.
21. Vigneron A, Roninson IB, Gamelin E, Coqueret O. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1. Cancer Res 2005, 65:8927-8935. 10.1158/0008-5472.CAN-05-0461, 16204065.
22. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996, 381:713-716. 10.1038/381713a0, 8649519.
23. Ouyang Z, Zhou Q, Wong WH. ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells. Proc Natl Acad Sci USA 2009, 106:21521-21526. 10.1073/pnas.0904863106, 2789751, 19995984.
24. Wanzel M, Herold S, Eilers M. Transcriptional repression by Myc. Trends Cell Biol 2003, 13:146-150. 10.1016/S0962-8924(03)00003-5, 12628347.
25. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 2005, 6:1054-1060. 10.1038/ni1245, 16142238.
26. Basu S, Liu Q, Qiu Y, Dong F. Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc Natl Acad Sci USA 2009, 106:1433-1438. 10.1073/pnas.0804863106, 2635772, 19164764.
27. Courapied S, Sellier H, De Carne Trecesson S, Vigneron A, Bernard AC, Gamelin E, Barre B, Coqueret O. The cdk5 kinase regulates the STAT3 transcription factor to prevent DNA damage Upon topoisomerase I inhibition. J Biol Chem 2010, PMID: 20516069.
28. Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113:703-716. 10.1016/S0092-8674(03)00401-X, 12809602.
29. Kramer A, Lukas J, Bartek J. Checking out the centrosome. Cell Cycle 2004, 3:1390-1393.
30. Kingston RE, Narlikar GJ. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 1999, 13:2339-2352. 10.1101/gad.13.18.2339, 10500090.
31. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005, 6:635-645. 10.1038/nrm1703, 16064138.
32. Eberhardy SR, Farnham PJ. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J Biol Chem 2001, 276:48562-48571.
33. Eberhardy SR, Farnham PJ. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J Biol Chem 2002, 277:40156-40162. 10.1074/jbc.M207441200, 12177005.
34. Herold S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T, Syvaoja J, Saluz HP, Haenel F, Eilers M. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 2002, 10:509-521. 10.1016/S1097-2765(02)00633-0, 12408820.
35. Wanzel M, Kleine-Kohlbrecher D, Herold S, Hock A, Berns K, Park J, Hemmings B, Eilers M. Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage. Nat Cell Biol 2005, 7:30-41. 10.1038/ncb1202, 15580267.
36. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 2002, 9:1031-1044. 10.1016/S1097-2765(02)00520-8, 12049739.